Aims This study aimed to: (a) determine adherence rates to oral anticoagulants in atrial fibrillation patients with a high risk for thromboembolic events postradiofrequency ablation; (b) evaluate patients' knowledge and perceptions towards oral anticoagulants; and (c) explore the impact of patients' knowledge and perceptions on treatment adherence. BackgroundDesignAtrial fibrillation is a common arrhythmia associated with an increased risk of developing thromboembolic events such as stroke. Although adherence to oral anticoagulants is crucial to prevent such complications, the relationship between adherence, knowledge and patient perceptions is poorly understood in patients with atrial fibrillation at high risk for thromboembolic events aft...
We investigated real-life oral anticoagulation (OAC) treatment after surgical ablation and examined ...
Oral anticoagulation is pivotal in the management of thromboembolic risk in non-valvular atrial fibr...
Aim. To study adherence to treatment with new oral anticoagulants (NOAC) and factors associated with...
Background:Patients' knowledge regarding their oral anticoagulant (OAC) treatment for stroke prevent...
[[abstract]]Objective To investigate anticoagulant adherence and its associated factors, including d...
[[abstract]]Objective: To investigate anticoagulant adherence and its associated factors, including ...
Background: The aim of this study was to investigate the proportion of patients who have suboptimal ...
BackgroundNon-adherence to medications is common in patients with atrial fibrillation (AF), increasi...
Abstract: Introduction Stroke prevention using oral anticoagulation (OAC) is the first management pr...
© 2018 John Wiley & Sons Ltd Background: Atrial fibrillation (AF) is the most commonly diagnosed a...
Objective: The overall aim of this dissertation was to provide a better understanding of adherence ...
© 2018, The Author(s) 2018. Background: The aim of this study was to investigate the proportion of p...
The purpose of this European Heart Rhythm Association survey was to assess the attitude, level of ed...
Background Non-vitamin K antagonist oral anticoagulants (NOAC) have superior safety and comparable e...
© 2016, Springer International Publishing Switzerland. The role of the direct oral anticoagulants (D...
We investigated real-life oral anticoagulation (OAC) treatment after surgical ablation and examined ...
Oral anticoagulation is pivotal in the management of thromboembolic risk in non-valvular atrial fibr...
Aim. To study adherence to treatment with new oral anticoagulants (NOAC) and factors associated with...
Background:Patients' knowledge regarding their oral anticoagulant (OAC) treatment for stroke prevent...
[[abstract]]Objective To investigate anticoagulant adherence and its associated factors, including d...
[[abstract]]Objective: To investigate anticoagulant adherence and its associated factors, including ...
Background: The aim of this study was to investigate the proportion of patients who have suboptimal ...
BackgroundNon-adherence to medications is common in patients with atrial fibrillation (AF), increasi...
Abstract: Introduction Stroke prevention using oral anticoagulation (OAC) is the first management pr...
© 2018 John Wiley & Sons Ltd Background: Atrial fibrillation (AF) is the most commonly diagnosed a...
Objective: The overall aim of this dissertation was to provide a better understanding of adherence ...
© 2018, The Author(s) 2018. Background: The aim of this study was to investigate the proportion of p...
The purpose of this European Heart Rhythm Association survey was to assess the attitude, level of ed...
Background Non-vitamin K antagonist oral anticoagulants (NOAC) have superior safety and comparable e...
© 2016, Springer International Publishing Switzerland. The role of the direct oral anticoagulants (D...
We investigated real-life oral anticoagulation (OAC) treatment after surgical ablation and examined ...
Oral anticoagulation is pivotal in the management of thromboembolic risk in non-valvular atrial fibr...
Aim. To study adherence to treatment with new oral anticoagulants (NOAC) and factors associated with...